Mb. Sholar et al., CONCURRENT PHARMACOKINETIC ANALYSIS OF PLASMA COCAINE AND ADRENOCORTICOTROPIC HORMONE IN MEN, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 966-968
The purpose of this study was to determine the covariance between plas
ma cocaine and ACTH pharmacokinetics. Twelve healthy male occasional c
ocaine users participated in a double blind study. Intravenous cocaine
(0.2 mg/kg) or placebo was infused over 1 min, and samples for cocain
e, ACTH and cortisol analysis were collected at 2, 4, 8, 12, 16, 20, 3
0, 40, 60, 80, 120, 180, and 240 min. Peak cocaine plasma levels avera
ged 101.2 +/- 14.6 ng/mL. ACTH increases were significantly correlated
(P < 0.0001) with increases in plasma cocaine levels (r = 0.67; r(2)
= 0.44). Pharmacokinetic analysis showed that the t(max) (observed tim
e to maximum concentration) values for cocaine (6.0 +/- 1.4 min) and A
CTH (7.3 +/- 1.2 min) were almost identical. The area under the curve
was calculated using the trapezoidal rule. The area under the curve fo
r plasma cocaine was 6463 +/- 1070 ng/min.mL, and the area under the c
urve for ACTH was 1873 +/- 188 pmol/min.L. The mean half-life for plas
ma cocaine was 46.7 +/- 4.0 min, and that for ACTH was 35.8 +/- 5.1 mi
n. Cardiovascular and subjective effect measures were correlated with
concurrent increases in plasma cocaine and ACTH levels.